Houghten; Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Houghten; Richard.The latest application filed is for "compounds and methods of treating neurological disorders".

Company Profile

0.11.10

Houghten; Richard - Port St. Lucie FL
Houghten; Richard - Solana Beach CA
Houghten; Richard -
Houghten; Richard - Del Mar CA
Houghten; Richard - Solhna Beach CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and methods of treating neurological disorders Grant 9,994,536 - Lakshmana , et al. June 12, 2	2018-06-12
Compounds And Methods Of Treating Neurological Disorders App 20170121296 - LAKSHMANA; MADEPALLI K. ; et al.	2017-05-04
Compounds And Methods Of Treating Neurological Disorders App 20150315179 - Lakshmana; Madepalli K. ; et al.	2015-11-05
Conjugates of membrane translocating agents and pharmaceutically active agents Grant 8,017,727 - O'Mahony , et al. September 13, 2	2011-09-13
Conjugates Of Membrane Translocating Agents And Pharmaceutically Active Agents App 20100168381 - O'Mahony; Daniel ; et al.	2010-07-01
Conjugates of membrane translocating agents and pharmaceutically active agents Grant 7,638,599 - O'Mahony , et al. December 29, 2	2009-12-29
Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 Grant 7,166,296 - Houghten , et al. January 23, 2	2007-01-23
Pharmaceutical Formulations and Ligands for Use Therein; Mimetics for UEA-1 App 20060276628 - Houghten; Richard ; et al.	2006-12-07
Inhibiting furin with polybasic peptides App 20060241050 - Cameron; Angus ; et al.	2006-10-26
Conjugates of membrane translocating agents and pharmaceutically active agents App 20060100149 - O'Mahony; Daniel ; et al.	2006-05-11
Inhibiting furin with polybasic peptides Grant 7,033,991 - Lindberg , et al. April 25, 2	2006-04-25
Conjugates of membrane translocating agents and pharmaceutically active agents App 20050101762 - O'Mahony, Daniel ; et al.	2005-05-12
Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 App 20040062796 - Houghten, Richard ; et al.	2004-04-01
Conjugates of membrane translocating agents and pharmaceutically active agents App 20030181367 - O'Mahony, Daniel ; et al.	2003-09-25
Inhibiting furin with polybasic peptides App 20030087827 - Lindberg, Iris ; et al.	2003-05-08
N-methyl-d-aspartate receptor channel blockers and method for identifying such Grant 6,251,854 - Montal , et al. June 26, 2	2001-06-26
Combinatorial libraries of cyclic urea and cyclic thiourea derivatives and compounds therein Grant 5,786,448 - Nefzi , et al. July 28, 1	1998-07-28
Mycobacterial recombinants and peptides Grant 5,478,726 - Shinnick , et al. December 26, 1	1995-12-26
Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides Grant 5,116,725 - Vaughan , et al. May 26, 1	1992-05-26
Mycobacterial recombinants and peptides Grant 4,952,395 - Shinnick , et al. August 28, 1	1990-08-28
Platelet binding inhibitors Grant 4,683,291 - Zimmerman , et al. July 28, 1	1987-07-28

Company Registrations

NCAGE Code	4BDA7	HOUGHTEN RICHARD
CAGE Code	4BDA7	HOUGHTEN, RICHARD

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.